Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




ELISA Reader Features Modern Light Source, Small Footprint

By LabMedica International staff writers
Posted on 09 Oct 2012
Performance features of a new microplate absorbance reader include optimized optics, a modern light source of principally unlimited lifetime, and a multiple-filter capacity that enables a broad range of applications.

The Apollo 11 ELISA Absorbance Reader provided by Berthold Technologies (Bad Wildbad, Germany), a company specializing in bioanalytical instruments for diagnostics and research, is a product of long-time, continuous optimization of ELISA reader technology and in particular introduces its new unlimited life-time LED light source technology. More...
The instrument also has the capacity to install up to six filters, enabling a variety of applications in one system, including DNA quantification, protein quantification, various enzyme activity assays including beta-Galactosidase and for immunoassay/ELISA - alkaline phosphatase and horseradish peroxidase. For extraordinary accuracy and precision (providing dependable measurement repeatability and traceable, comparable results), the Apollo 11 reader has an unusually large dynamic range of 0 to 3.7 OD, sophisticated optics, a robust mechanical design, and an integrated function that performs autocheck and autocalibration of the optics and electronics before every measurement.

An additional valuable feature is the PhotoRead software for showing on a single screen: data, commands, settings, and displays needed during operation. The easy-to-use self-explaining one-view PhotoRead software also allows initiation of measurements within seconds. Microplate shaking can be adjusted from a choice of 4 amplitudes and 4 speeds. Also notable is that the unit’s small footprint size (210 x 281 x 160 mm) saves valuable laboratory space.

Related Links:

Berthold Technologies


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.